Scope of the Study
The cytogenetics media is used in culturing human peripheral blood cells, bone, marrow, T-cell lymphocytes, and other human specimens for cytogenetic analysis. It is used basically for the study of chromosomes, for example, the analysis is very important for the diagnosis, classification, prognosis, and management of acute myeloid leukemia (AML) which can be only done with the help of cytogenetics media. This test helps doctors and researchers to help identify potential diseases like leukemia and provide proper treatment guidance. Cytogenetic testing is generally done through the bone marrow of AML patients and helps in categorizing the level of leukemia and it also assists in treatment response and overall prognosis.
The market study is being classified by Type (Basal Medium, Complete Medium, Chromosome Medium, Bone Marrow Medium and Others), by Application (Cytogenetics Laboratories, Medical Center, Scientific Research and Others) and major geographies with country level break-up.
Thermo Fisher Scientific Inc. (United States), FUJIFILM Irvine Scientific (United States), Biological Industries (United States), Precipio, Inc. (United States), TRINOVA BIOCHEM GmbH (Germany), Zotal Biological and Instrumentation (Israel) and Sanbio B.V. (Netherlands) are some of the key players profiled in the study.
AdvanceMarketAnalytics has segmented the market of Global Cytogenetics Media market by Type, Application and Region.
On the basis of geography, the market of Cytogenetics Media has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- The growing need for the study of chromosomes for the proper diagnosis and treatment of the genetic issues in the body. The cytogenetics media optimizes the performance of the cell, increase consistency during the analysis. The genetically evolved problems need treatment where cytogenetics analysis helps.
- Technological Advancements in Cytogenetics Analysis
- Continuous Research and Development for Cytogenetics Media
- The Time-Consuming Process Associated with the Research and Production of Cytogenetics Media
- Growing Research and Development Infrastructure
- High Cost Involved with Cytogenetics Media
On 2nd July 2019, Fujifilm Irvine Scientific Inc. which is a global leader in the innovation, development, and manufacture of cell culture media, announced its plans to open a third manufacturing facility located in Tilburg, Netherlands. The company currently has sites in the United States and Japan. Fujifilm’s investment in this project demonstrates its commitment to accelerate development in bioproduction, and cell and gene therapy markets.
"According to the Medical laboratories – Requirements for quality and competence legislation standards the general, routine cytogenetic analysis should consist of a minimum of 5 banded cells analyzed, 10 cells counted (in addition to the already counted cells). In cases where clinically relevant mosaicism is suspected, counting, analysis or scoring of at least 30 cells is recommended to exclude mosaicism of 10% at the 0.95 confidence level. For cancer cytogenetics, if no chromosomal abnormality is found in the first five cells analyzed, then a further five cells are to be fully analyzed and an additional 10 cells are to be counted."
Key Target Audience
Cytogenetics Media Manufacturer, Cytogenetics Media International Traders, Cytogenetics Media Distributors and Suppliers, Research and Development Institutes, Regulatory Bodies, Industry Associations, Potential Investors and Others
Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase